DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
McElvaney OJ, McEvoy NL, Boland F. et al.
A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for ARDS secondary to COVID-19.
Med (N Y) 2022;
3 (04) 233-248.e6
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.